𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SUCI02 inhibits the erbB-2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells

✍ Scribed by Xiao-Feng Zhu; Jing-Song Wang; Li-Ling Cai; Yi-Xin Zeng; Dajun Yang


Book ID
108583586
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
219 KB
Volume
97
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Bidirectional interactions between the e
✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/

Targeted inhibition of the epidermal gro
✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (β€˜Iressa’), an orally a

Direct inhibition of interleukin-2 recep
✍ Deborah J. Kuhn; Q. Ping Dou πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 359 KB

## Abstract Overexpression of the interleukin‐2 receptor (IL‐2R) Ξ± chain in tumor cells is associated with tumor progression and a poor patient prognosis. IL‐2RΞ± is responsible for the high affinity binding of the receptor to IL‐2, leading to activation of several proliferative and anti‐apoptotic i